[Disease-modifying treatment approaches in Huntington disease : Past and future].

Abstract excerpt

Huntington disease (HD) is the most frequent monogenetic neurodegenerative disease and can be unequivocally diagnosed even in the preclinical stage, at least in all individuals in whom the CAG expansion mutation in the huntingtin gene (HTT) is in the range of full penetrance. Therefore, important preconditions for an intervention early in the disease process are met, rendering modification of the course of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brain
• Share to Huntingtin Protein
• Share to Huntington Disease